Prevention and treatment of rheumatic heart disease in the developing world.

Andrew Steer, Jonathan Carapetis

    Research output: Contribution to journalArticlepeer-review


    The prevalence of rheumatic heart disease (RHD) in industrialized countries has declined dramatically over the last century, but the disease remains an important global health problem with the burden of disease shouldered by developing countries. Indeed, data from epidemiologic surveys, which used echocardiography as the primary screening tool, indicate that the prevalence of RHD in developing nations might have been substantially underestimated. Despite the high burden of disease globally, there has never been a sustained and comprehensive international strategy to control RHD. The current focus of global efforts to combat the disease is on strengthening secondary prophylaxis strategies, although very few active national programs have been implemented. RHD will continue to cause high morbidity and mortality among the world's poorest populations unless current prevention initiatives expand and new programs are established. � 2009 Macmillan Publishers Limited. All rights reserved.
    Original languageEnglish
    Pages (from-to)689-698
    Number of pages10
    JournalNature Reviews Cardiology
    Issue number11
    Publication statusPublished - 2009


    Dive into the research topics of 'Prevention and treatment of rheumatic heart disease in the developing world.'. Together they form a unique fingerprint.

    Cite this